Drug Safety: Another big Indian drug firm fails to meet standards. Warning letters are issued to firms that, during an inspection by FDA officials, are found to breach pharmaceutical manufacturing regulations. Recipients of the letters are often, but not always, banned in the U.S. from selling finished drugs and active ingredients made at their noncompliant facilities.
